Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs
about
Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis.Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.Reliability of the MB/BacT system for testing susceptibility of Mycobacterium tuberculosis complex isolates to antituberculous drugs.Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis.Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosisAntimicrobial susceptibility testing of Mycobacterium tuberculosis complex for first and second line drugs by broth dilution in a microtiter plate format.Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method.Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis.Simple fibroblast-based assay to test the pyrazinamide susceptibility of Mycobacterium tuberculosis.Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosis
P2860
Q33946393-E0FB3772-6805-40E7-9CC8-78C4F9AC2791Q33962909-8CAB660F-9EA9-45A1-8498-40A0CC5DD531Q33965642-C24D897D-9B1F-4A99-84FC-F002DDB9B5DBQ34990099-8860F3E5-742D-4AFD-A844-331B707905B4Q36359595-F64323FC-F4AB-4447-ADA1-B00EA9BD6F66Q36600075-742A6E45-11F1-47F9-BCEA-F781B50D4089Q38758659-D46BE52B-38D1-49F7-8B61-B86BAA74099CQ39453039-59801875-E0AD-4CD5-A8BE-08F3E2325212Q39462719-FCD1FEE0-87B4-4E0B-A722-761F8EBAEDD6Q40599116-CDBED965-E4E0-4C7F-B054-E5447D5194E6Q41002998-20B8E539-7A9D-4FCA-951C-7A05DB64AF75Q41483651-743FD440-E71F-455E-8C75-2D6A281BEA7D
P2860
Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Evaluation of the ESP culture ...... primary antituberculous drugs
@ast
Evaluation of the ESP culture ...... primary antituberculous drugs
@en
type
label
Evaluation of the ESP culture ...... primary antituberculous drugs
@ast
Evaluation of the ESP culture ...... primary antituberculous drugs
@en
prefLabel
Evaluation of the ESP culture ...... primary antituberculous drugs
@ast
Evaluation of the ESP culture ...... primary antituberculous drugs
@en
P2860
P1476
Evaluation of the ESP culture ...... primary antituberculous drugs
@en
P2093
J S Bergmann
P2860
P304
P407
P577
1998-10-01T00:00:00Z